Birth prevalence and determinants of neural tube defects among newborns in Ethiopia: A systematic review and meta-analysis
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0315122 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2025. Verfasst von Beminet Moges Gebremariam und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia. Hauptthemen laut MEDLINE: Neural Tube Defects. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neural tube defects (NTDs) are complex multifactorial disorders in the neurulation of the brain and spinal cord that develop in humans between 21 and 28 days of conception. Neonates with NTDs may experience morbidity and mortality, with severe social and economic consequences. Therefore, the aim of this systematic review and meta-analysis is to assess the pooled prevalence and determinants for neural tube defects among newborns in Ethiopia.
Methods
The protocol of this study was registered in the International Prospective Register of Systematic Reviews (PROSPERO Number: CRD42023407095). We systematically searched the databases PubMed, Science Direct, Cochrane Library, Google Scholar and Research Gate. Grey literature was searched on Google. Heterogeneity among studies was assessed using the I 2 test statistic and the Cochran Q test statistic. A random effects model was used to estimate the birth prevalence of neural tube defects.
Result
Twenty-five articles were included in the meta-analysis to estimate the prevalence and determinants of neural tube defects in Ethiopia. A total of 611,354 newborns were included in the analysis. The pooled birth prevalence of neural tube defects was 83.40 (95% CI: 60.78, 106.02) per 10,000 births. The highest and lowest prevalence rates were 130.9 (95% CI: 113.52, 148.29) in Tigray and 28.60 (95% CI: 18.70, 38.50) per 10,000 births in Amhara regional states. Women’s intake of folic acid supplements and planned pregnancy were identified as protective factors for NTDs, while stillbirth history, use of any drugs during pregnancy, exposure to radiation, and pesticides during pregnancy were risk factors for neural tube defects.
Conclusion
The pooled birth prevalence of neural tube defects in Ethiopia was found to be high. Effective prevention interventions, especially focusing on periconceptional folic acid supplementation as well as folate fortification, should be prioritized alongside nutrition education, maternal health care, and environmental safety measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Public Health, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia.
- School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.
- Department of Nutritional Sciences, Oklahoma State University, Stillwater, Oklahoma, United States of America.
- Department of Public Health Sciences, College of Medicine and Health Sciences, Mekelle University, Mekelle, Ethiopia.
ORCID-Profile: Beminet Moges Gebremariam
Zitieren
APA
Gebremariam, B. M., Hailu, D., Stoecker, B. J., & Mulugeta, A. (2025). Birth prevalence and determinants of neural tube defects among newborns in Ethiopia: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0315122
Vancouver
Gebremariam BM, Hailu D, Stoecker BJ, Mulugeta A. Birth prevalence and determinants of neural tube defects among newborns in Ethiopia: A systematic review and meta-analysis. PLOS ONE. 2025. doi:10.1371/journal.pone.0315122
BibTeX
@article{Gebremariam2025,
author = {Gebremariam, Beminet Moges and Hailu, Dejene and Stoecker, Barbara J and Mulugeta, Afework},
title = {Birth prevalence and determinants of neural tube defects among newborns in Ethiopia: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0315122}
}
EUVIMED